Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
16 Apr 2024
Haemophilia A Treatment Shows No Racial or Ethnic Divide
Researchers have found no significant differences in the effectiveness of immune tolerance induction therapy across different racial and ethnic groups in individuals living with haemophilia A.
4
Mins
27 Mar 2024
Interview: Pier Mannuccio Mannucci
I think the beginning was when I graduated in the 1960s; my thesis was on red cell enzymes within haematology, but it had nothing to do…
20 Mar 2024
Opioid Misuse Rare in Children with Sickle Cell Disease
Providing opioid prescriptions to children who have experienced pain due to sickle cell disease does not lead to harmful patterns of opioid use. Read more.
19 Mar 2024
Individualised Predictive Model for Multiple Myeloma
A novel classification model for multiple myeloma may provide personalised predictions of treatment outcomes for individual patients. This research has the potential to significantly improve current management of MM.
3
Mins
14 Mar 2024
Non-Factor Therapies in Current Clinical Practice
The 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) took place on 6th–9th February 2024 in…
12 Mar 2024
EAHAD 2024 – Interview with the Congress President
EMJ sat down with EAHAD President, Wolfgang Miesbach, live at this year’s congress in Frankfurt, Germany. Miesbach highlighted key…
8
Mins
4 Mar 2024
IgD Multiple Myeloma
Multiple myeloma (MM) is a disease characterised by the clonal expansion of malignant plasma cells in the marrow, leading to anaemia…
9
Mins
29 Feb 2024
Sickle Cell Thalassaemia and Overlapping Syndrome
Sickle cell disease (SCD) is a genetic condition caused by mutations in the haemoglobin (Hb) gene, resulting in various complications. One…
Loading posts...
« Previous
1
…
47
48
49
50
51
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View